Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Epoetin beta adverse reaction |
Causative agent |
True |
Epoetin beta (substance) |
Inferred relationship |
Some |
1 |
Allergy to epoetin beta |
Causative agent |
False |
Epoetin beta (substance) |
Inferred relationship |
Some |
|
Product containing epoetin beta (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Epoetin beta (substance) |
Inferred relationship |
Some |
1 |
epoetin beta 50.000 IE pulver og solvent til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epoetin beta (substance) |
Inferred relationship |
Some |
|
epoetin beta 100.000 IE pulver og solvent til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epoetin beta (substance) |
Inferred relationship |
Some |
|
epoetin beta 10.000 IE pulver og solvent til injektionsvæske, opløsning, cylinderampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epoetin beta (substance) |
Inferred relationship |
Some |
|
epoetin beta 20.000 IE pulver og solvent til injektionsvæske, opløsning, cylinderampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epoetin beta (substance) |
Inferred relationship |
Some |
|
epoetin beta 500 IE pulver og solvent til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epoetin beta (substance) |
Inferred relationship |
Some |
|
epoetin beta 500 IE injektionsvæske, opløsning i fyldt injektionssprøjte a 0,3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epoetin beta (substance) |
Inferred relationship |
Some |
|
epoetin beta 1000 IE injektionsvæske, opløsning i fyldt injektionssprøjte a 0,3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epoetin beta (substance) |
Inferred relationship |
Some |
|
epoetin beta 2000 IE injektionsvæske, opløsning i fyldt injektionssprøjte a 0,3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epoetin beta (substance) |
Inferred relationship |
Some |
|
epoetin beta 3000 IE injektionsvæske, opløsning i fyldt injektionssprøjte a 0,3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epoetin beta (substance) |
Inferred relationship |
Some |
|
epoetin beta 5000 IE injektionsvæske, opløsning i fyldt injektionssprøjte a 0,3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epoetin beta (substance) |
Inferred relationship |
Some |
|
epoetin beta 10.000 IE injektionsvæske, opløsning i fyldt injektionssprøjte a 0,6 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epoetin beta (substance) |
Inferred relationship |
Some |
|
epoetin beta 60.000 IE pulver og solvent til injektionsvæske, opløsning, cylinderampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epoetin beta (substance) |
Inferred relationship |
Some |
|
epoetin beta 6000 IE injektionsvæske, opløsning i fyldt injektionssprøjte a 0,3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epoetin beta (substance) |
Inferred relationship |
Some |
|
epoetin beta 4000 IE injektionsvæske, opløsning i fyldt injektionssprøjte a 0,3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epoetin beta (substance) |
Inferred relationship |
Some |
|
epoetin beta 20.000 IE/ml injektionsvæske, opløsningi fyldt injektionssprøjte a 0,6 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epoetin beta (substance) |
Inferred relationship |
Some |
|
epoetin beta 30.000 IE injektionsvæske, opløsning i fyldt injektionssprøjte a 0,6 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epoetin beta (substance) |
Inferred relationship |
Some |
|
Methoxy polyethylene glycol-epoetin beta (substance) |
Is a |
False |
Epoetin beta (substance) |
Inferred relationship |
Some |
|
Allergy to epoetin beta |
Causative agent |
True |
Epoetin beta (substance) |
Inferred relationship |
Some |
1 |
Methoxy polyethylene glycol-epoetin beta (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Epoetin beta (substance) |
Inferred relationship |
Some |
|
Epoetin beta 10,000iu powder for conventional release solution for injection cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epoetin beta (substance) |
Inferred relationship |
Some |
|
Epoetin beta 100,000iu powder for conventional release solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epoetin beta (substance) |
Inferred relationship |
Some |
|
Epoetin beta 20,000iu powder for conventional release solution for injection cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epoetin beta (substance) |
Inferred relationship |
Some |
|
Epoetin beta 50,000iu powder for conventional release solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epoetin beta (substance) |
Inferred relationship |
Some |
|
Epoetin beta 60,000iu powder for conventional release solution for injection cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epoetin beta (substance) |
Inferred relationship |
Some |
|
Product containing precisely epoetin beta 10000 unit/0.6 milliliter conventional release solution for injection syringe |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Epoetin beta (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely epoetin beta 10000 unit/0.6 milliliter conventional release solution for injection syringe |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Epoetin beta (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely epoetin beta 1000 unit/0.3 milliliter conventional release solution for injection syringe |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Epoetin beta (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely epoetin beta 1000 unit/0.3 milliliter conventional release solution for injection syringe |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Epoetin beta (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely epoetin beta 2000 unit/0.3 milliliter conventional release solution for injection syringe |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Epoetin beta (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely epoetin beta 2000 unit/0.3 milliliter conventional release solution for injection syringe |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Epoetin beta (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely epoetin beta 30000 unit/0.6 milliliter conventional release solution for injection syringe |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Epoetin beta (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely epoetin beta 30000 unit/0.6 milliliter conventional release solution for injection syringe |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Epoetin beta (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely epoetin beta 3000 unit/0.3 milliliter conventional release solution for injection syringe |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Epoetin beta (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely epoetin beta 3000 unit/0.3 milliliter conventional release solution for injection syringe |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Epoetin beta (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely epoetin beta 5000 unit/0.3 milliliter conventional release solution for injection syringe |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Epoetin beta (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely epoetin beta 5000 unit/0.3 milliliter conventional release solution for injection syringe |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Epoetin beta (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely epoetin beta 500 unit/0.3 milliliter conventional release solution for injection syringe |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Epoetin beta (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely epoetin beta 500 unit/0.3 milliliter conventional release solution for injection syringe |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Epoetin beta (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely epoetin beta 6000 unit/0.3 milliliter conventional release solution for injection syringe |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Epoetin beta (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely epoetin beta 6000 unit/0.3 milliliter conventional release solution for injection syringe |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Epoetin beta (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely epoetin beta 4000 unit/0.3 milliliter conventional release solution for injection syringe |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Epoetin beta (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely epoetin beta 4000 unit/0.3 milliliter conventional release solution for injection syringe |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Epoetin beta (substance) |
Inferred relationship |
Some |
1 |
Product containing epoetin beta in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Epoetin beta (substance) |
Inferred relationship |
Some |
1 |
Product containing only epoetin beta (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Epoetin beta (substance) |
Inferred relationship |
Some |
1 |
Epoetin beta only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Epoetin beta (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely epoetin beta 16667 unit/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Epoetin beta (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely epoetin beta 16667 unit/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Epoetin beta (substance) |
Inferred relationship |
Some |
1 |
Epoetin beta 1667 unit/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Epoetin beta (substance) |
Inferred relationship |
Some |
1 |
Epoetin beta 1667 unit/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Epoetin beta (substance) |
Inferred relationship |
Some |
1 |
Epoetin beta 10000 unit/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Epoetin beta (substance) |
Inferred relationship |
Some |
1 |
Epoetin beta 10000 unit/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Epoetin beta (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely epoetin beta 50000 unit/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Epoetin beta (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely epoetin beta 50000 unit/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Epoetin beta (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely epoetin beta 6667 unit/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Epoetin beta (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely epoetin beta 6667 unit/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Epoetin beta (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely epoetin beta 13333 unit/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Epoetin beta (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely epoetin beta 13333 unit/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Epoetin beta (substance) |
Inferred relationship |
Some |
1 |
Epoetin beta 20000 unit/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Epoetin beta (substance) |
Inferred relationship |
Some |
1 |
Epoetin beta 20000 unit/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Epoetin beta (substance) |
Inferred relationship |
Some |
1 |
Epoetin beta 3333 unit/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Epoetin beta (substance) |
Inferred relationship |
Some |
1 |
Epoetin beta 3333 unit/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Epoetin beta (substance) |
Inferred relationship |
Some |
1 |